RIYADH, Saudi Arabia, Oct. 30, 2023 (GLOBE NEWSWIRE) — In a groundbreaking development for the Middle East, King Faisal Specialist Hospital and Research Centre (KFSH&RC) has introduced a service called Rapid Whole-Genome Sequencing (rWGS) as part of its healthcare solutions. This service is designed to help doctors diagnose rare and genetic disorders, particularly in critically ill newborns, who require fast and precise identification of their conditions.
The Rapid Whole Genome Sequencing service is invaluable for newborns with rare diseases, as it helps them avoid the often lengthy process of tests and treatments that can stretch for months or even years without a precise diagnosis. This increases the chances of survival and reduces the overall healthcare cost by minimizing hospital admissions, unnecessary tests, and medical care.
Remarkably, the hospital has reduced the time required for this genetic testing from the typical two-month duration to less than 35 hours. Response time is paramount when planning healthcare for critically ill newborns, and swift delivery of test results ensures a prompt and tailored medical response, preventing delays that could otherwise lead to worsening the patient’s condition or even death.
As part of its participation in the Global Health Summit, where KFSH&RC plays a vital role as a strategic healthcare partner, the hospital shares details about the Rapid Whole Genome Sequencing service at its exhibition booth. The hospital’s cutting-edge capabilities include analyzing up to 99% of DNA sequences from patient blood samples, along with several innovative healthcare solutions.
The comprehensive genetic composition examination involves a streamlined four-step process. First, the DNA is broken down into manageable segments. Then, it is encoded with a barcode-like symbol for easy identification, similar to tracking products in a store. The examination itself is conducted using specialized equipment. Finally, advanced computer systems and software compare these sequences, identifying differences in DNA sequences and pinpointing the genetic mutations responsible for diseases.
KFSH&RC provides the highest level of healthcare and offers the best possible patient experience within an integrated educational and research environment. It collaborates and shares expertise with leading local, regional, and international institutions to provide a globally competitive service in clinical, research, and educational fields.
Globally renowned for its specialized healthcare, KFSH&RC is a pioneer in medical innovation and a hub for advanced medical research and education. It is committed to advancing medical technologies and raising the standard of healthcare worldwide through partnerships with top local, regional, and international institutions in clinical, research, and educational sectors.
Contact information:
kfshrc@mcsaatchi.com
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/59bc8aa4-5f6d-432a-b4e9-c26544e9aa6d
https://www.globenewswire.com/NewsRoom/AttachmentNg/76f80d26-8e56-42df-b95a-c8cdab80e449
